Exhibit 4.1


 


THIS WARRANT AND THE SECURITIES ISSUABLE
UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES
LAWS OF ANY STATE. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A REGISTRATION
STATEMENT IN EFFECT WITH RESPECT TO SUCH SECURITIES UNDER SUCH ACT AND QUALIFICATION UNDER APPLICABLE STATE SECURITIES LAWS, OR
AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION AND QUALIFICATION IS NOT REQUIRED.


 


BIOHITECH GLOBAL, INC.


 


COMMON STOCK PURCHASE WARRANT


 


	Warrant Shares: ____	Issue Date:  October  __, 2020


 


 


THIS COMMON STOCK PURCHASE
WARRANT (the “Warrant”) certifies that, for value received, __________, a New York limited liability
company or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise
and the conditions hereinafter set forth, to purchase from the Company at any time after the Issue Date until 5:00 p.m., E.S.T
on the fifth (5th) anniversary of the Issue Date (the “Termination Date”) but not thereafter,
to subscribe for and purchase from BioHiTech Global, Inc., a Delaware corporation (the “Company”), up
to Fifty Thousand (50,000) shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common
Stock, par value $0.0001 per share (the “Common Stock”). The purchase price of one share of Common Stock
under this Warrant shall be equal to the Exercise Price, as set forth below.


 


The following
is a statement of the rights of the Holder of this Warrant and the conditions to which this Warrant is subject, to which the Holder,
by the acceptance of this Warrant, agrees:


 


1.         Certain
Definitions.


 


1.1         “Exercise
Price” means a price per share equal to the price per share, as measured by the average of the high and low prices
as published on the Nasdaq Capital Market on the issue date set forth above.


 


1.2         “Expiration
Date” means the date that is five (5) years after the issue date set forth above.


 


1.3         “Shares”
or “Warrant Shares” means the shares of Common Stock issuable under this Warrant, as set forth above.


 


2.         Number
of Shares and Exercise.


 






     


     


    

 


2.1         This
Warrant shall be exercisable for such number of Warrant Shares as set forth above, at the Exercise Price.


 


2.2         This
Warrant may be exercised in whole or in part at any time beginning on the date on which the Initial Exercise Date and continuing
thereafter and from time to time on or prior to the Expiration Date.


 


3.          Exercise
of Warrant


 


3.1         The
purchase rights represented by this Warrant are exercisable by the Holder, in whole or in part, by the surrender of this Warrant
and the Notice of Exercise annexed hereto duly executed at the Company’s principal executive office (or such other office
or agent of the Company as it may designate by notice in writing to the Holder at the address of the Holder appearing on the books
of the Company), and upon payment of the aggregate Exercise Price of the Shares thereby purchased (by check or bank draft payable
to the order of the Company); whereupon the Holder shall be entitled to receive the number of Shares so purchased. The Company
agrees that if at the time of the surrender of this Warrant and purchase of the Shares, the Holder shall be entitled to exercise
this Warrant, the Shares so purchased shall be issued to the Holder as the record owner of such Shares as of the close of business
on the date on which this Warrant shall have been exercised as aforesaid or on such later date requested by the Holder or on such
earlier date agreed to by the Holder and the Company.


 


3.2       Delivery
of Common Stock Certificates and New Warrant. As soon as reasonably practicable after each exercise of this Warrant, in
whole or in part, and in any event within five (5) business days thereafter (the “Warrant Share Delivery Date”),
the Company, at its expense (including the payment by it of any applicable issue taxes), will cause the name of the Holder (or
as Holder may direct) to be entered in the register of holders in respect of the Warrant Shares and further cause to be issued
in the name of and delivered to the Holder hereof or as the Holder (upon payment by the Holder of any applicable transfer taxes)
may direct:


 


(a)         the
number of duly authorized, validly issued, fully paid and nonassessable Warrant Shares to which the Holder shall be entitled upon
exercise, in certificated form with appropriate restrictive legends, if applicable; and


 


(b)         in
case exercise is in part only, a new Warrant document of like tenor, dated the date hereof, for the remaining number of Warrant
Shares issuable upon exercise of this Warrant after giving effect to the partial exercise of this Warrant (including the delivery
of any Warrant Shares as payment of the Exercise Price for such partial exercise of this Warrant).


 


4.          Nonassessable.
The Company covenants that all Shares which may be issued upon the exercise of this Warrant will be validly issued, fully paid
and nonassessable and free from all taxes, liens and charges in respect of the issue thereof.


 


5.          Fractional
Shares. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant.
With respect to any fraction of a share called for upon the exercise of this Warrant, the number of shares delivered shall be rounded
up to the nearest whole share.


 






     


     


    

 


6.          Charges,
Taxes and Expenses. Issuance of Shares upon the exercise of this Warrant, in certificated form or otherwise, shall be made
without charge to the Holder hereof for any issue or transfer tax or other incidental expense in respect of the issuance, including
relating to any certificate, all of which taxes and expenses shall be paid by the Company, and such Shares shall be issued in the
name of the Holder.


 


7.         No
Rights as Shareholders. This Warrant does not entitle the Holder to any voting rights or other rights as a shareholder
of the Company prior to the exercise hereof.


 


8.           Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall be a Saturday, a Sunday or a legal holiday, then such action may be taken or such right may be exercised
on the next succeeding day that is not a Saturday, Sunday or legal holiday.


 


9.           Adjustments.
The Exercise Price and the number of Shares purchasable hereunder are subject to adjustment from time to time as set forth in this
Section 9.


 


9.1       Reclassification,
etc. If the Company, at any time while this Warrant, or any portion thereof, remains outstanding and unexpired, by reclassification
of securities or otherwise, shall change the class of the securities as to which purchase rights under this Warrant exist into
the same or a different number of securities or any other class or classes of securities, this Warrant shall thereafter represent
the right to acquire such number and kind of securities as would have been issuable as the result of such change with respect to
the securities that were subject to the purchase rights under this Warrant immediately prior to such reclassification or other
change and the Exercise Price therefor shall be appropriately adjusted, all subject to further adjustment as provided in this Section
9.


 


9.2       Subdivision
or Combination of Shares. In the event the Company shall at any time subdivide the outstanding securities as to which
purchase rights under this Warrant exist, or shall issue a stock dividend on the securities as to which purchase rights under this
Warrant exist, the number of securities as to which purchase rights under this Warrant exist immediately prior to such subdivision
or to the issuance of such stock dividend shall be proportionately increased, and the Exercise Price shall be proportionately decreased,
and in the event that the Company shall at any time combine the outstanding securities as to which purchase rights under this Warrant
exist, the number of securities as to which purchase rights under this Warrant exist immediately prior to such combination shall
be proportionately decreased, and the Exercise Price shall be proportionately increased, effective at the close of business on
the date of such subdivision, stock dividend or combination, as the case may be.


 


9.3       Cash
Distributions. No adjustment on account of cash dividends or interest on the securities as to which purchase rights under
this Warrant exist will be made to the Exercise Price under this Warrant.


 


10.         Miscellaneous.


 


10.1      Loss,
Theft, Destruction or Mutilation of Warrant. Upon receipt of evidence reasonably satisfactory to the Company of the loss,
theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, delivery of an indemnity agreement
reasonably satisfactory in form and substance to the Company or, in the case of mutilation, on surrender and cancellation of this
Warrant, the Company shall execute and deliver, in lieu of this Warrant, a new Warrant executed in the same manner as this Warrant
and of like tenor and amount.


 






     


     


    

 


10.2      Waivers
and Amendments. This Warrant and the obligations of the Company and the rights of the Holder under this Warrant may be
amended, waived, discharged or terminated (either generally or in a particular instance, either retroactively or prospectively
and either for a specified period of time or indefinitely) with the written consent of the Company (which shall not be required
in connection with a waiver of rights in favor of the Company); provided, however, that no such amendment
or waiver shall reduce the number of Shares represented by this Warrant without the consent of the Holder hereof; and provided
further, however, that nothing shall prevent the Holder from individually agreeing to waive the observation of any term of
this Warrant. Any amendment, waiver, discharge or termination effected in accordance with this Section 10.2 shall be binding upon
the Company, the Holder, and except pursuant to a waiver by an individual holder of another Warrant pursuant to the final proviso
in the immediately preceding sentence, each other holder of Warrants.


 


10.3      Notices. Any
notice, request or other communication required or permitted hereunder shall be given in writing and given by registered or certified
mail, return receipt requested, or by Federal Express or other recognized overnight courier requiring a receipt upon delivery,
addressed to the registered address of the party or to such address as any party may designate in writing to all other parties
in accordance with this paragraph.


 


10.4      Severability. If
one or more provisions of this Warrant are held to be unenforceable under applicable law, such provision(s) shall be excluded from
this Warrant and the balance of this Warrant shall be interpreted as if such provision(s) were so excluded and shall be enforceable
in accordance with its terms.


 


10.5      Successors
and Assigns. Neither this Warrant nor any rights hereunder are transferable without the prior written consent of
the Company. Notwithstanding the foregoing, the Holder shall be permitted to transfer this Warrant to any affiliate (as that term
is defined in the Securities Act of 1933, as amended) of the Holder. If a transfer is permitted pursuant to this Section, the transfer
shall be recorded on the books of the Company upon the surrender of this Warrant, properly endorsed, to the Company at its principal
offices, and the payment to the Company of all transfer taxes and other governmental charges imposed on such transfer. In the event
of a partial transfer, the Company shall issue to the holders one or more appropriate new warrants. Subject to the foregoing, the
provisions of this Warrant shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators
of the Company and the Holder.


 


10.6      Delays
or Omissions. No delay or omission to exercise any right, power, or remedy accruing to the Holder, upon any breach or
default of the Company under this Warrant shall impair any such right, power, or remedy of the Holder nor shall it be construed
to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter
occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default therefore or
thereafter occurring. Any waiver, permit, consent, or approval of any kind or character on the part of the Holder of any breach
or default under this Warrant or any waiver on the part of the Holder of any provisions or conditions of this Warrant must be made
in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Warrant
or by law or otherwise afforded to the Holder, shall be cumulative and not alternative.


 






     


     


    

 


10.7      Titles
and Subtitles. The titles of the paragraphs and subparagraphs of this Warrant are for convenience of reference only and
are not to be considered in construing this Warrant.


 


10.8      Construction. The
language used in this Warrant will be deemed to be the language chosen by the parties to express their mutual intent and no rules
of strict construction will be applied against any party.


 


10.9      Governing
Law. THIS WARRANT SHALL BE GOVERNED IN ALL RESPECTS BY THE LAWS OF THE STATE OF DELAWARE AS SUCH LAWS ARE APPLIED TO AGREEMENTS
BETWEEN DELAWARE RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN DELAWARE.


 


[Remainder of page intentionally
left blank]


 




     


     


    


 


 


IN WITNESS WHEREOF,
BioHiTech Global, Inc. has caused this Warrant to be executed by its officer thereunto duly authorized.


  


  


	BIOHITECH GLOBAL, INC. 	 
	 	 
	 	 	 
	By: 	 	 
	 	Name:	 
	 	Title:	 


 


 


 


 


 




     


     


    


 


 


THIS WARRANT AND THE SECURITIES ISSUABLE
UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES
LAWS OF ANY STATE. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A REGISTRATION
STATEMENT IN EFFECT WITH RESPECT TO SUCH SECURITIES UNDER SUCH ACT AND QUALIFICATION UNDER APPLICABLE STATE SECURITIES LAWS, OR
AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION AND QUALIFICATION IS NOT REQUIRED.


 


BIOHITECH GLOBAL, INC.


 


COMMON STOCK PURCHASE WARRANT


 


	Warrant Shares: 50,000	Issue Date:  October 19, 2020


 


 


THIS COMMON STOCK PURCHASE
WARRANT (the “Warrant”) certifies that, for value received, LEK HOLDINGS, LLC, a New York limited liability
company or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise
and the conditions hereinafter set forth, to purchase from the Company at any time after the Issue Date until 5:00 p.m., E.S.T
on the fifth (5th) anniversary of the Issue Date (the “Termination Date”) but not thereafter,
to subscribe for and purchase from BioHiTech Global, Inc., a Delaware corporation (the “Company”), up
to Fifty Thousand (50,000) shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common
Stock, par value $0.0001 per share (the “Common Stock”). The purchase price of one share of Common Stock
under this Warrant shall be equal to the Exercise Price, as set forth below.


 


The following
is a statement of the rights of the Holder of this Warrant and the conditions to which this Warrant is subject, to which the Holder,
by the acceptance of this Warrant, agrees:


 


1.         Certain
Definitions.


 


1.1         “Exercise
Price” means a price per share equal to the price per share, as measured by the average of the high and low prices
as published on the Nasdaq Capital Market on the issue date set forth above.


 


1.2         “Expiration
Date” means the date that is five (5) years after the issue date set forth above.


 


1.3         “Shares”
or “Warrant Shares” means the shares of Common Stock issuable under this Warrant, as set forth above.


 


2.         Number
of Shares and Exercise.


 






     


     


    

 


2.1         This
Warrant shall be exercisable for such number of Warrant Shares as set forth above, at the Exercise Price.


 


2.2         This
Warrant may be exercised in whole or in part at any time beginning on the date on which the Initial Exercise Date and continuing
thereafter and from time to time on or prior to the Expiration Date.


 


3.          Exercise
of Warrant


 


3.1         The
purchase rights represented by this Warrant are exercisable by the Holder, in whole or in part, by the surrender of this Warrant
and the Notice of Exercise annexed hereto duly executed at the Company’s principal executive office (or such other office
or agent of the Company as it may designate by notice in writing to the Holder at the address of the Holder appearing on the books
of the Company), and upon payment of the aggregate Exercise Price of the Shares thereby purchased (by check or bank draft payable
to the order of the Company); whereupon the Holder shall be entitled to receive the number of Shares so purchased. The Company
agrees that if at the time of the surrender of this Warrant and purchase of the Shares, the Holder shall be entitled to exercise
this Warrant, the Shares so purchased shall be issued to the Holder as the record owner of such Shares as of the close of business
on the date on which this Warrant shall have been exercised as aforesaid or on such later date requested by the Holder or on such
earlier date agreed to by the Holder and the Company.


 


3.2       Delivery
of Common Stock Certificates and New Warrant. As soon as reasonably practicable after each exercise of this Warrant, in
whole or in part, and in any event within five (5) business days thereafter (the “Warrant Share Delivery Date”),
the Company, at its expense (including the payment by it of any applicable issue taxes), will cause the name of the Holder (or
as Holder may direct) to be entered in the register of holders in respect of the Warrant Shares and further cause to be issued
in the name of and delivered to the Holder hereof or as the Holder (upon payment by the Holder of any applicable transfer taxes)
may direct:


 


(a)         the
number of duly authorized, validly issued, fully paid and nonassessable Warrant Shares to which the Holder shall be entitled upon
exercise, in certificated form with appropriate restrictive legends, if applicable; and


 


(b)         in
case exercise is in part only, a new Warrant document of like tenor, dated the date hereof, for the remaining number of Warrant
Shares issuable upon exercise of this Warrant after giving effect to the partial exercise of this Warrant (including the delivery
of any Warrant Shares as payment of the Exercise Price for such partial exercise of this Warrant).


 


4.          Nonassessable.
The Company covenants that all Shares which may be issued upon the exercise of this Warrant will be validly issued, fully paid
and nonassessable and free from all taxes, liens and charges in respect of the issue thereof.


 


5.          Fractional
Shares. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant.
With respect to any fraction of a share called for upon the exercise of this Warrant, the number of shares delivered shall be rounded
up to the nearest whole share.


 






     


     


    

 


6.          Charges,
Taxes and Expenses. Issuance of Shares upon the exercise of this Warrant, in certificated form or otherwise, shall be made
without charge to the Holder hereof for any issue or transfer tax or other incidental expense in respect of the issuance, including
relating to any certificate, all of which taxes and expenses shall be paid by the Company, and such Shares shall be issued in the
name of the Holder.


 


7.         No
Rights as Shareholders. This Warrant does not entitle the Holder to any voting rights or other rights as a shareholder
of the Company prior to the exercise hereof.


 


8.           Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall be a Saturday, a Sunday or a legal holiday, then such action may be taken or such right may be exercised
on the next succeeding day that is not a Saturday, Sunday or legal holiday.


 


9.           Adjustments.
The Exercise Price and the number of Shares purchasable hereunder are subject to adjustment from time to time as set forth in this
Section 9.


 


9.1       Reclassification,
etc. If the Company, at any time while this Warrant, or any portion thereof, remains outstanding and unexpired, by reclassification
of securities or otherwise, shall change the class of the securities as to which purchase rights under this Warrant exist into
the same or a different number of securities or any other class or classes of securities, this Warrant shall thereafter represent
the right to acquire such number and kind of securities as would have been issuable as the result of such change with respect to
the securities that were subject to the purchase rights under this Warrant immediately prior to such reclassification or other
change and the Exercise Price therefor shall be appropriately adjusted, all subject to further adjustment as provided in this Section
9.


 


9.2       Subdivision
or Combination of Shares. In the event the Company shall at any time subdivide the outstanding securities as to which
purchase rights under this Warrant exist, or shall issue a stock dividend on the securities as to which purchase rights under this
Warrant exist, the number of securities as to which purchase rights under this Warrant exist immediately prior to such subdivision
or to the issuance of such stock dividend shall be proportionately increased, and the Exercise Price shall be proportionately decreased,
and in the event that the Company shall at any time combine the outstanding securities as to which purchase rights under this Warrant
exist, the number of securities as to which purchase rights under this Warrant exist immediately prior to such combination shall
be proportionately decreased, and the Exercise Price shall be proportionately increased, effective at the close of business on
the date of such subdivision, stock dividend or combination, as the case may be.


 


9.3       Cash
Distributions. No adjustment on account of cash dividends or interest on the securities as to which purchase rights under
this Warrant exist will be made to the Exercise Price under this Warrant.


 


10.         Miscellaneous.


 


10.1      Loss,
Theft, Destruction or Mutilation of Warrant. Upon receipt of evidence reasonably satisfactory to the Company of the loss,
theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, delivery of an indemnity agreement
reasonably satisfactory in form and substance to the Company or, in the case of mutilation, on surrender and cancellation of this
Warrant, the Company shall execute and deliver, in lieu of this Warrant, a new Warrant executed in the same manner as this Warrant
and of like tenor and amount.


 






     


     


    

 


10.2      Waivers
and Amendments. This Warrant and the obligations of the Company and the rights of the Holder under this Warrant may be
amended, waived, discharged or terminated (either generally or in a particular instance, either retroactively or prospectively
and either for a specified period of time or indefinitely) with the written consent of the Company (which shall not be required
in connection with a waiver of rights in favor of the Company); provided, however, that no such amendment
or waiver shall reduce the number of Shares represented by this Warrant without the consent of the Holder hereof; and provided
further, however, that nothing shall prevent the Holder from individually agreeing to waive the observation of any term of
this Warrant. Any amendment, waiver, discharge or termination effected in accordance with this Section 10.2 shall be binding upon
the Company, the Holder, and except pursuant to a waiver by an individual holder of another Warrant pursuant to the final proviso
in the immediately preceding sentence, each other holder of Warrants.


 


10.3      Notices. Any
notice, request or other communication required or permitted hereunder shall be given in writing and given by registered or certified
mail, return receipt requested, or by Federal Express or other recognized overnight courier requiring a receipt upon delivery,
addressed to the registered address of the party or to such address as any party may designate in writing to all other parties
in accordance with this paragraph.


 


10.4      Severability. If
one or more provisions of this Warrant are held to be unenforceable under applicable law, such provision(s) shall be excluded from
this Warrant and the balance of this Warrant shall be interpreted as if such provision(s) were so excluded and shall be enforceable
in accordance with its terms.


 


10.5      Successors
and Assigns. Neither this Warrant nor any rights hereunder are transferable without the prior written consent of
the Company. Notwithstanding the foregoing, the Holder shall be permitted to transfer this Warrant to any affiliate (as that term
is defined in the Securities Act of 1933, as amended) of the Holder. If a transfer is permitted pursuant to this Section, the transfer
shall be recorded on the books of the Company upon the surrender of this Warrant, properly endorsed, to the Company at its principal
offices, and the payment to the Company of all transfer taxes and other governmental charges imposed on such transfer. In the event
of a partial transfer, the Company shall issue to the holders one or more appropriate new warrants. Subject to the foregoing, the
provisions of this Warrant shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators
of the Company and the Holder.


 


10.6      Delays
or Omissions. No delay or omission to exercise any right, power, or remedy accruing to the Holder, upon any breach or
default of the Company under this Warrant shall impair any such right, power, or remedy of the Holder nor shall it be construed
to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter
occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default therefore or
thereafter occurring. Any waiver, permit, consent, or approval of any kind or character on the part of the Holder of any breach
or default under this Warrant or any waiver on the part of the Holder of any provisions or conditions of this Warrant must be made
in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Warrant
or by law or otherwise afforded to the Holder, shall be cumulative and not alternative.


 






     


     


    

 


10.7      Titles
and Subtitles. The titles of the paragraphs and subparagraphs of this Warrant are for convenience of reference only and
are not to be considered in construing this Warrant.


 


10.8      Construction. The
language used in this Warrant will be deemed to be the language chosen by the parties to express their mutual intent and no rules
of strict construction will be applied against any party.


 


10.9      Governing
Law. THIS WARRANT SHALL BE GOVERNED IN ALL RESPECTS BY THE LAWS OF THE STATE OF DELAWARE AS SUCH LAWS ARE APPLIED TO AGREEMENTS
BETWEEN DELAWARE RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN DELAWARE.


 


[Remainder of page intentionally
left blank]


 




     


     


    


 


 


IN WITNESS WHEREOF,
BioHiTech Global, Inc. has caused this Warrant to be executed by its officer thereunto duly authorized.


 


 


	BIOHITECH GLOBAL, INC. 	 
	 	 
	 	 	 
	By: 	 	 
	 	Name:	 
	 	Title:	 





  






     


     


    




 


NOTICE OF EXERCISE


 


	 	TO:	BioHiTech Global, Inc.
	 	 	80 Red Schoolhouse Road, Suite 101
	 	 	Chestnut Ridge, NY 10977
	 	 	Attn: Secretary


 


 


The undersigned hereby elects to purchase _______ shares (the
“Shares”) of the Common Stock of BioHiTech Global, Inc. pursuant to the terms of the attached Warrant
and tenders herewith payment of the purchase price in full.


 


Please issue the Shares, including in certificated form with
appropriate restrictive legends, if applicable, in the name of the undersigned or in such other name as is specified below:


 


	 
	(Print Name)


 


 


	Address:	 	 
	 	 
	 	 



 





The undersigned confirms that the undersigned
is an “accredited investor” within the meaning of Rule 501 of Regulation D under the Securities Act of 1933, as amended,
and that the Shares are being acquired for the account of the undersigned for investment only and not with a view to, or for resale
in connection with, the distribution thereof, and that the undersigned has no present intention of distributing or selling the
Shares.


 


	 	 	 
	(Date)	 	(Signature)
	 	 	 
	 	 	 
	(Print Name)	 	 


 


 


 




     


     


    


 


 


Exhibit C – Amended and Restated
Operating Agreement


 


See Attached